Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-29a-deficiency causes thickening of the basilar membrane and age-related hearing loss by upregulating collagen IV and laminin. | Front Cell Neurosci | 2023 | 37275774 | PubTator, text mining | PubMed |
| New insights from trio whole-exome sequencing in the children with kidney disease: A single-center retrospective cohort study. | Mol Genet Genomic Med | 2023 | 37248651 | PubTator, text mining | PubMed |
| Clinical diagnosis of genetic disorders at both single-nucleotide and chromosomal levels based on BGISEQ-500 platform. | Hum Genome Var | 2023 | 37217505 | PubTator, text mining | PubMed |
| Function and prognostic value of basement membrane -related genes in lung adenocarcinoma. | Front Pharmacol | 2023 | 37214471 | PubTator, text mining | PubMed |
| The potential regulatory role of RNA methylation in ovarian cancer. | RNA Biol | 2023 | 37194218 | PubTator, text mining | PubMed |
| Kidney Biopsy and Type IV Collagen Gene Sequencing Fail to Explain Hematuria in Loin Pain Hematuria Syndrome. | Kidney Int Rep | 2023 | 37180518 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis. | Clin Proteomics | 2023 | 37179321 | PubTator, text mining | PubMed |
| RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV. | Ann Med | 2023 | 37177979 | PubTator, text mining | PubMed |
| Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic Changes. | Cells | 2023 | 37174733 | PubTator, text mining | PubMed |
| Late chronic local inflammation, synaptic alterations, vascular remodeling and arteriovenous malformations in the brains of male rats exposed to repetitive low-level blast overpressures. | Acta Neuropathol Commun | 2023 | 37173747 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| Pediatric glomerulopathy after COVID-19 vaccination: A case series and review of the literature. | J Formos Med Assoc | 2023 | 37147241 | PubTator, text mining | PubMed |
| CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion. | Kidney360 | 2023 | 37143203 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of the ocular anterior segment: a comprehensive review. | Eye (Lond) | 2023 | 37138096 | PubTator, text mining | PubMed |
| Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome. | Elife | 2023 | 37129368 | PubTator, text mining | PubMed |
| Alport Syndrome: Clinical Spectrum and Therapeutic Advances. | Kidney Med | 2023 | 37122389 | PubTator, text mining | PubMed |
| Genotype-phenotype correlation of X-linked Alport syndrome observed in both genders: a multicenter study in South Korea. | Sci Rep | 2023 | 37100867 | PubTator, text mining | PubMed |
| Clinical, histological and molecular characteristics of Alport syndrome in Chinese children. | J Nephrol | 2023 | 37097554 | PubTator, text mining | PubMed |
| The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis. | Biomimetics (Basel) | 2023 | 37092398 | PubTator, text mining | PubMed |
| Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. | Front Immunol | 2023 | 37063851 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=17